Diclofenac in municipal wastewater treatment plant: Quantification using laser diode thermal desorption-atmospheric pressure chemical ionization-tandem mass spectrometry approach in comparison with an established liquid chromatography-electrospray ionization-tandem mass spectrometry method

Journal of Chromatography A

Volumn 1433, Issue , 2016, Pages 106-113

  Lonappan, Linson ^a   Pulicharla, Rama ^a   Rouissi, Tarek ^a   Brar, Satinder K ^a   Verma, Mausam ^b   Surampalli, Rao Y ^c   Valero, José R ^a  

^a CENTRE EAU TERRE ENVIRONNEMENT   (Canada)

^b CO 2 Solutions Inc ^*  (Canada)

^c UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Diclofenac emerging contaminant; LC ESI MS MS; LDTD APCI MS MS; Quantification; Wastewater; Wastewater sludge

Indexed keywords

ATMOSPHERIC IONIZATION; ATMOSPHERIC PRESSURE; CHROMATOGRAPHY; DESORPTION; ELECTROSPRAY IONIZATION; EXTRACTION; IONIZATION; IONIZATION OF LIQUIDS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; RECLAMATION; SEWAGE PUMPING PLANTS; SOLVENT EXTRACTION; SPECTROMETRY; SURFACE WATERS; THERMAL DESORPTION; ULTRASONIC APPLICATIONS; WASTEWATER; WATER TREATMENT PLANTS;

APCI-MS; EMERGING CONTAMINANT; LC-ESI-MS/MS; QUANTIFICATION; WASTEWATER SLUDGE;

WASTEWATER TREATMENT;

DICLOFENAC; SURFACE WATER; NONSTEROID ANTIINFLAMMATORY AGENT; SEWAGE; WASTE WATER; WATER POLLUTANT;

ACCELERATED SOLVENT EXTRACTION; ANALYTIC METHOD; ARTICLE; CANADA; CONCENTRATION (PARAMETERS); EXTRACTION; INTERMETHOD COMPARISON; LASER DIODE THERMAL DESORPTION ATMOSPHERIC PRESSURE CHEMICAL IONIZATION; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY; PRIORITY JOURNAL; SEPARATION TECHNIQUE; SLUDGE TREATMENT; TANDEM MASS SPECTROMETRY; ULTRASONIC ASSISTED EXTRACTION; URBAN AREA; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT; WATER ANALYSIS; ANALYSIS; ATMOSPHERIC PRESSURE; CHEMISTRY; COMPARATIVE STUDY; DIODE LASER; ELECTROSPRAY MASS SPECTROMETRY; PROCEDURES; SEWAGE; WASTE WATER; WATER POLLUTANT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATMOSPHERIC PRESSURE; CHROMATOGRAPHY, LIQUID; DICLOFENAC; LASERS, SEMICONDUCTOR; SEWAGE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84955442091     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2016.01.030     Document Type: Article

References (37)

1. Jones O.A., Voulvoulis N., Lester J.N. Human pharmaceuticals in the aquatic environment a review. Environ. Technol. 2001, 22:1383-1394.
2. Halling-Sørensen B., Nors Nielsen S., Lanzky P.F., Ingerslev F., Holten Lützhøft H.C., Jørgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment-a review. Chemosphere 1998, 36:357-393.
3. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment-a review. Sci. Total Environ. 2012, 429:123-155.
4. Khetan S.K., Collins T.J. Human pharmaceuticals in the aquatic environment: a challenge to green chemistry. Chem. Rev. 2007, 107:2319-2364.
5. McGettigan P., Henry D. Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries. PLoS Med. 2013, 10:e1001388.
6. E. Palmer, Top 20 generic molecules worldwide, in: , 2012, pp. special report. http://www.fiercepharma.com.
7. Zhang Y., Geissen S.U., Gal C. Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 2008, 73:1151-1161.
8. Zorita S., Martensson L., Mathiasson L. Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden. Sci. Total Environ. 2009, 407:2760-2770.
9. Fatta-Kassinos D., Hapeshi E., Achilleos A., Meric S., Gros M., Petrovic M., Barcelo D. Existence of pharmaceutical compounds in tertiary treated urban wastewater that is utilized for reuse applications. Water Resour. Manag. 2011, 25:1183-1193.
10. Langford K.H., Reid M., Thomas K.V. Multi-residue screening of prioritised human pharmaceuticals, illicit drugs and bactericides in sediments and sludge. J. Environ. Monit. 2011, 13:2284-2291.
11. Kunkel U., Radke M. Fate of pharmaceuticals in rivers: deriving a benchmark dataset at favorable attenuation conditions. Water Res. 2012, 46:5551-5565.
12. Gros M., Petrovic M., Ginebreda A., Barcelo D. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ. Int. 2010, 36:15-26.
13. Cleuvers M. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol. Environ. Saf. 2004, 59:309-315.
14. Oaks J.L., Gilbert M., Virani M.Z., Watson R.T., Meteyer C.U., Rideout B.A., Shivaprasad H.L., Ahmed S., Iqbal Chaudhry M.J., Arshad M., Mahmood S., Ali A., Ahmed Khan A. Diclofenac residues as the cause of vulture population decline in Pakistan. Natute 2004, 427:630-633.
15. Hernando M.D., Mezcua M., Fernández-Alba A.R., Barceló D. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 2006, 69:334-342.
16. Lawrence J.R., Swerhone G.D.W., Topp E., Korber D.R., Neu T.R., Wassenaar L.I. Structural and functional responses of river biofilm communities to the nonsteroidal anti-inflammatory diclofenac. Environ. Toxicol. Chem. 2007, 26:573-582.
17. Swan G.E., Cuthbert R., Quevedo M., Green R.E., Pain D.J., Bartels P., Cunningham A.A., Duncan N., Meharg A.A., Oaks J.L., Parry-Jones J., Shultz S., Taggart M.A., Verdoorn G., Wolter K. Toxicity of diclofenac to Gyps vultures. Biol. Lett. 2006, 2:279-282.
18. Prakash V., Pain D.J., Cunningham A.A., Donald P.F., Prakash N., Verma A., Gargi R., Sivakumar S., Rahmani A.R. Catastrophic collapse of Indian white-backed Gyps bengalensis and long-billed Gyps indicus vulture populations. Biol. Conserv. 2003, 109:381-390.
19. Puicharla R., Mohapatra D.P., Brar S.K., Drogui P., Auger S., Surampalli R.Y. A persistent antibiotic partitioning and co-relation with metals in wastewater treatment plant-chlortetracycline. J. Environ. Chem. Eng. 2014, 2:1596-1603.
20. Spongberg A.L., Witter J.D. Pharmaceutical compounds in the wastewater process stream in Northwest Ohio. Sci. Total Environ. 2008, 397:148-157.
21. Abdel-Hamid M.E., Novotny L., Hamza H. Determination of diclofenac sodium flufenamic acid, indomethacin and ketoprofen by LC-APCI-MS. J. Pharm. Biomed. Anal. 2001, 24:587-594.
22. Caban M., Migowska N., Stepnowski P., Kwiatkowski M., Kumirska J. Matrix effects and recovery calculations in analyses of pharmaceuticals based on the determination of β-blockers and β-agonists in environmental samples. J. Chromatogr. A 2012, 1258:117-127.
23. Langenhoff A., Inderfurth N., Veuskens T., Schraa G., Blokland M., Kujawa-Roeleveld K., Rijnaarts H. Microbial removal of the pharmaceutical compounds ibuprofen and diclofenac from wastewater. BioMed Res. Int. 2013, 2013:9.
24. Topuz E., Sari S., Ozdemir G., Aydin E., Pehlivanoglu-Mantas E., Okutman Tas D. Optimization of diclofenac quantification from wastewater treatment plant sludge by ultrasonication assisted extraction. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2014, 958:48-54.
25. Rogatsky E., Stein D. Evaluation of matrix effect and chromatography efficiency: new parameters for validation of method development. J. Am. Soc. Mass Spectrom. 2005, 16:1757-1759.
26. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75:3019-3030.
27. Leverence R., Avery M.J., Kavetskaia O., Bi H., Hop C.E.C.A., Gusev A.I. Signal suppression/enhancement in HPLC-ESI-MS/MS from concomitant medications. Biomed. Chromatogr. 2007, 21:1143-1150.
28. Gangl E.T., Annan M., Spooner N., Vouros P. Reduction of signal suppression effects in ESI-MS using a nanosplitting device. Anal. Chem. 2001, 73:5635-5644.
29. Martín J., Santos J.L., Aparicio I., Alonso E. Multi-residue method for the analysis of pharmaceutical compounds in sewage sludge, compost and sediments by sonication-assisted extraction and LC determination. J. Sep. Sci. 2010, 33:1760-1766.
30. Göbel A., Thomsen A., McArdell C.S., Alder A.C., Giger W., Theiß N., Löffler D., Ternes T.A. Extraction and determination of sulfonamides, macrolides, and trimethoprim in sewage sludge. J. Chromatogr. A 2005, 1085:179-189.
31. Yu Y., Wu L. Analysis of endocrine disrupting compounds, pharmaceuticals and personal care products in sewage sludge by gas chromatography-mass spectrometry. Talanta 2012, 89:258-263.
32. Zuloaga O., Navarro P., Bizkarguenaga E., Iparraguirre A., Vallejo A., Olivares M., Prieto A. Overview of extraction, clean-up and detection techniques for the determination of organic pollutants in sewage sludge: a review. Anal. Chim. Acta 2012, 736:7-29.
33. Löffler D., Ternes T.A. Determination of acidic pharmaceuticals, antibiotics and ivermectin in river sediment using liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2003, 1021:133-144.
34. Vieno N., Sillanpää M. Fate of diclofenac in municipal wastewater treatment plant-a review. Environ. Int. 2014, 69:28-39.
35. 2 treatments. Chemosphere 2009, 77:518-525.
36. 2 reaction. Desalin. Water Treat. 2013, 52:6211-6218.
37. 2 and ozone. Water Res. 2004, 38:414-422.